Nicholas Cassis Jr., M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 415 Morris St, Suite 300, Charleston, WV 25301 Phone: 304-345-6303 Fax: 304-345-6305 |
Dr. Lee Ann Skaff, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 4922 Maccorkle Ave Se, Charleston, WV 25304 Phone: 304-925-0923 Fax: 304-925-0960 |
Dr. Stephen R Grubb, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3100 Maccorkle Ave Se Ste 205, Charleston, WV 25304 Phone: 304-720-7305 Fax: 304-720-7310 |
Dr. Glenn Crotty Jr., MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 501 Morris St, Charleston, WV 25301 Phone: 304-388-7647 Fax: 304-388-7696 |
Dr. Ilia Bernstein, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 3100 Maccorkle Ave Se Ste 700, Charleston, WV 25304 Phone: 304-347-1395 |
Mrs. Raghda Tolaymat Sahloul, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4400 Maccorkle Avenue S.e., Charleston, WV 25304 Phone: 304-345-8665 Fax: 304-345-8662 |
News Archive
A novel treatment reduces heart damage after serious heart attacks in two animal models. Injections of two chemicals in a slow-release form significantly reduced the size of the dead heart tissue, known as the infarct, and improved the function of the left ventricle, as compared to untreated subjects.
Austin Recovery, the largest and most affordable not-for-profit drug and alcohol treatment center in Texas, has once again teamed up with the Emmy Award-winning "Intervention" program to save an addict's life.
A new study documents malformations seen in an infant born to a kidney transplant recipient who had taken mycophenolate mofetil (MMF), a widely used immunosuppressant available commercially as Cellcept.
A molecule that targets the cell's machinery for breaking down unneeded proteins can kill multiple myeloma cancer cells resistant to the frontline drug Velcade, researchers at Dana-Farber Cancer Institute have found.
The American Dental Association and the ADA Foundation today announced that the foundation's Anthony Volpe Research Center (VRC) received a five-year, $2.2 million grant from the National Institute of Dental and Craniofacial Research (NIDCR) to develop new resin composite dental fillings.
› Verified 1 days ago